The MiniMed 780G with the Simplera Sync CGM and accompanying devices ... Sync and MiniMed 780G combination in Europe. She said Medtronic hopes to bring that combination to the U.S. market this ...

Medtronic is hoping that their efforts in the AID and "smart dosing" markets will pay off after largely missing out on the CGM market. They may be onto something. The recent ADA guidelines do ...

Another neuromodulation innovation to watch for in the pipeline is Medtronic’s tibial implant for overactive bladder. Smart dosing for diabetes patients “is expected to dominate by the end of the ...

In this article, we are going to take a look at where Medtronic plc (NYSE:MDT) stands against other best dividend stocks to buy and hold. In recent years, many investors have shifted their focus ...

The first 24 hours of CGM wear have been a persistent weak spot across the industry, with sensor accuracy often fluctuating due to the body’s natural response to insertion. These advancements ...

Since the start of 2025, Medtronic plc (NYSE:MDT) has surged by nearly 10%. Earlier this year, the company secured US approval for its Simplera continuous glucose monitoring (CGM) system. In ...

We recently compiled a list of the 15 Stocks to Invest in with Steady Dividends. In this article, we are going to take a look at where Medtronic plc (NYSE:MDT) stands against the other dividend ...

Roche is teaming up with two medical tech companies to develop an automated insulin delivery system, the first steps towards an ‘artificial pancreas.’ The Swiss pharma will work with existing ...

“We believe that our patented technology—featuring a modular, eco-friendly design and cutting-edge sensor performance—represents a paradigm shift in the CGM market, which is projected to exceed $20 ...

Abstract: This paper presents the synthesis and performance of a novel flexible patch antenna sensor based on graphene nanoplatelets (GNP) material designed to operate at the 5.8 GHz frequency, ...